SB-207266. 5-HT4 Receptor agonist agent for irritable bowel syndrome

Drugs of the Future

Volumn 22, Issue 12, 1997, Pages 1325-1332

  Gaster, Laramie ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

N (1 BUTYLPIPERIDIN 4 YLMETHYL) 3,4 DIHYDRO 2H 1,3 OXAZINO[3,2 A]INDOLE 1 CARBOXAMIDE; PIBOSEROD; SEROTONIN 4 ANTAGONIST; SEROTONIN 4 RECEPTOR; UNCLASSIFIED DRUG;

CHRONOTROPISM; DESCENDING COLON; DOG; DOSE RESPONSE; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; ESOPHAGUS MUCOSA; GUINEA PIG; HEART ATRIUM; HIPPOCAMPUS; HUMAN; ILEUM; IN VITRO STUDY; IRRITABLE COLON; NONHUMAN; PERISTALSIS; REVIEW; SMOOTH MUSCLE CONTRACTION; SWINE;

EID: 0031422847     PISSN: 03778282     EISSN: None     Source Type: Journal    
DOI: 10.1358/dof.1997.022.12.436218     Document Type: Review

References (63)

1. 4 receptor. Med Res Rev 1993, 13: 633-62.
2. 4 receptor antagonists and their potential therapeutic utility. Drugs Fut 1994, 19: 1109-21.
3. 4 receptor antagonists. Exp Opin Ther Patents 1994, 4: 323-34.
4. 4 receptors. Trends Pharmacol Sci 1995, 16: 391-8.
5. 4 receptors. FASEB J 1996, 10: 1398-407.
6. 4 receptor antagonists. Med Res Rev 1997, 17: 163-214.
7. 4 receptor antagonist amide with oral activity. J Med Chem 1995, 38: 4760-3.
8. Wardle, K.A., Bingham, S., Ellis, E.S. et al. Selective and functional 5-hydroxytryptamine4 receptor antagonism by SB-207266. Brit J Pharmacol 1996, 118: 665-70.
9. 4 receptor-mediated contractions. Brit J Pharmacol 1993, 110: 1593-9.
10. Baxter, G.S., Craig, D.A., Clarke, D.E. 5-Hydroxytryptamine4 receptors mediate relaxation of the rat oesophageal tunica muscularis mucosae. Naunyn-Schmied Arch Pharmacol 1991, 343: 439-46.
11. 4 receptor. Brit J Pharmacol 1990, 100: 879-85.
12. 4 receptor antagonist SB-204070. Brit J Pharmacol 1994, 112: 105P.
13. 4 receptors. Brit J Pharmacol 1993, 110: 10P.
14. 4-like receptor in human colon circular muscle. Brit J Pharmacol 1995, 115: 172-6.
15. 4 receptor antagonist affinities of SB-207710, SB-205008 and SB-203186 in the human colon, rat esophagus and guinea-pig ileum peristaltic reflex. Naunyn-Schmied Arch Pharmacol 1996, 352: 132-40.
16. 4 receptor antagonist in human isolated gastrointestinal tissue. Brit J Pharmacol 1997, 120: 192P.
17. 4 receptor function. J Pharm Pharmacol 1995, 47: 219-22.
18. 4 receptor activation. Brit J Pharmacol 1991, 102: 563-4.
19. 4 receptor mediated facilitation of the emptying phase of the peristaltic reflex in the guinea-pig isolated ileum. Brit J Pharmacol 1993, 110: 1572-8.
20. 4 receptor activation in the mouse. Eur J Pharmacol 1996, 308: 181-6.
21. Hedge, S.S., Moy, T.M., Perry, M.R., Loeb, M., Eglen, R.M. Evidence for the involvement of 5-hydroxytryptamine-4 receptors in 5-hydroxytryptophan-induced diarrhoea in mice. J Pharmacol Exp Ther 1994, 271: 741-7.
22. Thompson, W.G., Creed, F., Drossman, D.A., Heaton, K.W., Mazzacca, G. Functional bowel disease and functional abdominal pain. Gastroenterol Int 1992, 5: 75-91.
23. McQuay, H.J., Moore, R.A. Antidepressants and chronic pain: Effective analgesia in neuropathic pain and other syndromes. Brit Med J 1997, 314: 763-4.
24. Sanger, G.J. 5-Hydroxytryptamine and functional bowel disorders. Neurogastroenterol Motil 1996, 8: 319-31.
25. Read, N.W. Visceral afferent innervation and functional bowel disease: Evidence for dyssensation and altered reflex function. In: Basic & Clinical Aspects of Chronic Abdominal Pain, E.A. Mayer and H.E. Raybould (Eds.). Elsevier Science, 1993, 87-96.
26. Mayer, E.A., Munakata, J., Mertz, H. et al. Visceral hyperalgesia and irritable bowel syndrome. In: Visceral Pain, Progress in Pain Research and Management, Vol. 5, G.F. Gebhart (Ed.), IASP Press, Seattle, 1995, 429-68.
27. Collins, S.M., McHugh, K., Jacobson, K. et al. Previous inflammation alters the response of the rat colon to stress. Gastroenterology 1996, 111: 1509-15.
28. Mayer, E.A., Gebhart, G.F. Basic and clinical aspects of visceral hyperalgesia. Gastroenterology 1994, 107: 271-93.
29. Fargeas, M.J., Fioramonto, J., Bueno, L. The role of monoaminergic systems in central IL-1β-induced changes in intestinal motility. Neurogastroenterol Motil 1994, 6: 189-95.
30. Warner, R.R.P., Feldman, M.G., Warner, G.M. et al. Changes in blood serotonin concentration in mechanical obstruction of the small intestine. II. Findings in patients with intestinal obstruction. Surgery 1966, 59: 758.
31. Roseto, A., Cavaleri, F., Debons-Guillemin, M.C. et al. Human rotaviruses increase serotonin release from intestinal carcinoid cells cultured in vitro. Ann Virol 1981, 132E: 383-8.
32. Uribe, A., Alam, M., Johansson, O. et al. Microflora modulates endocrine cells in the gastrointestinal mucosa of the rat. Gastroenterology 1994, 107: 1259-69.
33. Cook, A.J., Woolfe, C.J., Wall, P.D., McMahon, S.B. Dynamic receptive field plasticity in rat spinal cord dorsal horn following C-primary afferent input. Nature 1987, 325: 151-3.
34. Accarino, A.M., Azpiroz, F., Malegelada, J.-R. Selective dysfunction of mechanosensitive intestinal afferents in irritable bowel syndrome. Gastroenterology 1995, 108: 636-43.
35. Ahonen, A., Kyosola, K., Penttila, O. Enterochromaffin cells and macrophages in ulcerative colitis and irritable colon. Ann Clin Res 1976, 8: 1-7.
36. Kyosola, K., Penttila, O., Salaspuro, M. Rectal mucosal adrenergic innervation and enterochromaffin cells in ulcerative colitis and irritable colon. Scand J Gastroenterol 1977, 12: 363-7.
37. Munglani, R., Harrison, S.M., Smith, G.D., Bountra, C., Birch, P.J., Elliot, P.J., Hunt, S.P. Neuropeptide changes persist in spinal cord despite resolving hyperalgesia in a rat model of mononeuropathy. Brain Res 1996, 743: 102-8.
38. Silverman, D.H.S., Munakata, J.A., Ennes, H. et al. Regional cerebral activity in normal and pathological perception of visceral pain. Gastroenterology 1997, 112: 64-72.
39. Burks, T.F., Long, J.P. Catecholamine-induced release of 5-hydroxytryptamine from perfused vasculature of isolated dog intestine. J Pharm Sci 1966, 55: 1383-6.
40. Pettersson, G. The neuronal control of the serotonin content in mammalian enterochromaffin cells. Acta Physiol Scand 1979, 470(Suppl.): 1-30.
41. Warner, R.R.P. Hyperserotonemia in functional gastrointestinal disease. Ann Intern Med 1963, 59: 464-76.
42. Shimizudani, T. Changes in the blood-serotonin levels in cases of upper gastrointestinal tract diseases. Tokyo Ika Diagaku 1973, 31: 713-33.
43. Kowlessar, O.D., Williams, R.C., Law, D.H., Sleisenger, M.H. Urinary excretion of 5-hydroxyindoleacetic acid in diarrhoeal states, with special reference to nontropical sprue. New Engl J Med 1958, 259: 340-1.
44. Ritchie, P.K., Knight, H.H., Ashby, M., Judd, A.M. Serotonin increases interleukin-6 release and decreases tumor necrosis factor release from rat adrenal zona glomerulosa cell in vitro. Endocrine 1996, 5: 291-7.
45. 3 receptor antagonists. Prog Palliative Care 1996, 4: 7-8.
46. Sanger, G.J., Wardle, K.A. 5-Hydroxytryptamine and cholinergic function in the gastrointestinal tract. In: Serotonin: From Cell Biology to Pharmacology and Therapeutics, R. Paoletti et al. (Eds.), Kluwer, 1990, 251-5.
47. 4 receptor agonists and antagonists. In: Receptor in the Brain and Periphery, R.M. Eglen (Ed.), Landes Bioscience/Springer-Verlag, 1997, in press.
48. Sanger, G.J. The pharmacology of anti-emetic agents. In: Emesis and Anti-Cancer Therapy. Mechanisms and Treatment, P.L.R. Andrews and G.J. Sanger (Eds.), Chapman & Hall Medical, 1993, 179-210.
49. 3 pathways in healthy humans. Gastroenterology 1997, 112: A700.
50. Foxx-Orenstein, A.E., Kuemmerle, J.F., Grider, J.R. Distinct 5-HT receptors mediate the peristaltic reflex induced by mucosal stimuli in human and guinea-pig intestine. Gastroenterology 1996, 111: 1281-90.
51. 1P receptors on sensory CGRP neurons. Amer J Physiol 1996, 270: G778-82.
52. Wade, P.R., Chen, J., Jaffe, B., Kassem, I.S., Blakely, R.D., Gershon, M.D. Localisation and function of a 5-HT transporter in crypt epithelia of the gastrointestinal tract. J Neurosci 1996, 16: 2352-64.
53. Moore, B.A., Sharkey, K.A., Mantle, M. Role of 5-HT in cholera toxin-induced mucin secretion in the rat small intestine. Amer J Physiol 1996, 270: G1001-9.
54. 4 receptor antagonist. Brit J Pharmacol 1995, 115: 1087-95
55. 4 antagonists of stress-induced colonic dysfunction and visceral pain in the rat. Gastroenterology 1996, 110: A735.
56. Cardenas, C.G., Delmar, L.L., Cooper, B.Y., Scroggs, R.S. 5-HT receptors couple positively to tetrodotoxin-insensitive sodium channels in a subpopulation of capsaicin-sensitive rat sensory neurons. J Neurosci 1997, 17: 7181-9.
57. Randich, A., Gebhart, G.F. Vagal afferent modulation of nociception. Brain Res Rev 1992, 17: 77-99.
58. 4 receptor antagonists, in three rat models of anxiety. Brit J Pharmacol 1997, 120: 138P.
59. 4 receptor antagonists on rat behaviour in the elevated plus-maze test. Eur J Pharmacol 1996, 309: 219-22.
60. 4 receptor activation in the rat hippocampus. Naunyn-Schmied Arch Pharmacol 1997, 355: 14-9.
61. 4 receptor. Int Clin Psychopharmacol 1993, 8(Suppl. 2): 11-8.
62. 4 receptor antagonists attenuate the disinhibitory effects of diazepam in the mouse light/dark test. Brit J Pharmacol 1996, 119: 352P.
63. 4 antagonism in irritable bowel syndrome (IBS): Effect of SB-207266-A on rectal sensitivity and small bowel transit. Gut 1997, 41(Suppl. 3): Abst 17.09.